Autoimmune polyendocrinopathy type 4

Autoimmune polyendocrinopathy type 4 (APS-4, also called autoimmune polyglandular syndrome type 4) is a rare autoimmune condition in which the immune system mistakenly attacks multiple endocrine (hormone-producing) glands and potentially other organs. It is classified as a form of autoimmune polyendocrinopathy that does not fit neatly into the more well-defined types 1, 2, or 3. APS-4 encompasses combinations of autoimmune endocrine disorders that fall outside the classic groupings — for example, combinations that do not include Addison disease with autoimmune thyroid disease or type 1 diabetes (which would characterize APS-2 or APS-3), or the triad seen in APS-1. The condition can affect a wide range of endocrine glands and organ systems. Patients may develop autoimmune destruction of glands such as the adrenals, thyroid, parathyroids, gonads, or pancreatic islet cells, leading to hormonal deficiencies. Non-endocrine autoimmune manifestations — such as vitiligo, pernicious anemia, celiac disease, or alopecia — may also occur. Symptoms depend on which glands and organs are involved and can include fatigue, weight changes, skin pigmentation abnormalities, hypoglycemia or hyperglycemia, menstrual irregularities, and muscle weakness. Treatment is primarily supportive and involves hormone replacement therapy tailored to the specific endocrine deficiencies present in each patient (e.g., thyroid hormone, corticosteroids, insulin, or sex hormones). Immunosuppressive therapies are sometimes considered but are not standard. Lifelong monitoring by an endocrinologist is essential, as new autoimmune manifestations can develop over time. Early detection and management of each component disorder are critical to reducing morbidity and improving quality of life.

Common questions about Autoimmune polyendocrinopathy type 4